These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11853149)

  • 41. A Clostridium botulinum type B vaccine for prevention of shaker foal syndrome.
    Thomas RJ; Rosenthal DV; Rogers RJ
    Aust Vet J; 1988 Mar; 65(3):78-80. PubMed ID: 3041951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunization with recombinant alpha toxin partially protects broiler chicks against experimental challenge with Clostridium perfringens.
    Cooper KK; Trinh HT; Songer JG
    Vet Microbiol; 2009 Jan; 133(1-2):92-7. PubMed ID: 18635321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunization with a nontoxic naturally occurring Clostridium perfringens alpha toxin induces neutralizing antibodies in rabbits.
    Siqueira FF; Silva ROS; do Carmo AO; de Oliveira-Mendes BBR; Horta CCR; Lobato FCF; Kalapothakis E
    Anaerobe; 2018 Feb; 49():48-52. PubMed ID: 29246841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
    Nagahama M; Oda M; Kobayashi K; Ochi S; Takagishi T; Shibutani M; Sakurai J
    Microbiol Immunol; 2013 May; 57(5):340-5. PubMed ID: 23668605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model.
    Guo S; Yan W; McDonough SP; Lin N; Wu KJ; He H; Xiang H; Yang M; Moreira MA; Chang YF
    Vaccine; 2015 Mar; 33(13):1586-95. PubMed ID: 25698490
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Standards for Clostridium chauvoei vaccine--the relationship between the response of guinea pigs and sheep following vaccination and challenge with virulent C. chauvoei.
    Crichton R; Harriss DA; McKay DJ
    Aust Vet J; 1986 Mar; 63(3):68-70. PubMed ID: 3729832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral vaccination of broiler chickens against necrotic enteritis using a non-virulent NetB positive strain of Clostridium perfringens type A.
    Mishra N; Smyth JA
    Vaccine; 2017 Dec; 35(49 Pt B):6858-6865. PubMed ID: 29102330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development, preparation and safety testing of a Clostridium welchii type C toxoid. II. Laboratory evaluation of potency.
    Knight PA; Lucken RN; Foster W; Walker PD
    J Biol Stand; 1979; 7(4):373-81. PubMed ID: 231607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The control of necrotic enteritis in sucking piglets by means of a Clostridium perfringens toxoid vaccine.
    Springer S; Selbitz HJ
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):333-6. PubMed ID: 10397319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization.
    Siddiqui F; O'Connor JR; Nagaro K; Cheknis A; Sambol SP; Vedantam G; Gerding DN; Johnson S
    J Infect Dis; 2012 Jan; 205(1):128-33. PubMed ID: 22124129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.
    de Bruyn G; Saleh J; Workman D; Pollak R; Elinoff V; Fraser NJ; Lefebvre G; Martens M; Mills RE; Nathan R; Trevino M; van Cleeff M; Foglia G; Ozol-Godfrey A; Patel DM; Pietrobon PJ; Gesser R;
    Vaccine; 2016 Apr; 34(19):2170-8. PubMed ID: 27013431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytotoxin CctA, a major virulence factor of Clostridium chauvoei conferring protective immunity against myonecrosis.
    Frey J; Johansson A; Bürki S; Vilei EM; Redhead K
    Vaccine; 2012 Aug; 30(37):5500-5. PubMed ID: 22749595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maternal vaccination against subclinical necrotic enteritis in broilers.
    Lovland A; Kaldhusdal M; Redhead K; Skjerve E; Lillehaug A
    Avian Pathol; 2004 Feb; 33(1):83-92. PubMed ID: 14681072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunization of pigs with a purified Shiga-like toxin II variant toxoid.
    MacLeod DL; Gyles CL
    Vet Microbiol; 1991 Nov; 29(3-4):309-18. PubMed ID: 1837635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of booster vaccination with a multivalent clostridial bacterin-toxoid on sudden death syndrome mortality rate among feedlot cattle.
    De Groot B; Dewey CE; Griffin DD; Perino LJ; Moxley RA; Hahn GL
    J Am Vet Med Assoc; 1997 Sep; 211(6):749-53. PubMed ID: 9301747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
    Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
    Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.
    Gupta RK; Anderson R; Cecchini D; Rost B; Griffin P; Benscoter K; Xu J; Montanez-Ortiz L; Siber GR
    Dev Biol Stand; 1996; 86():283-96. PubMed ID: 8785957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.
    Goossens E; Verherstraeten S; Valgaeren BR; Pardon B; Timbermont L; Schauvliege S; Rodrigo-Mocholí D; Haesebrouck F; Ducatelle R; Deprez PR; Van Immerseel F
    BMC Vet Res; 2016 Jun; 12(1):101. PubMed ID: 27297520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical courses of seven survivors of Clostridium septicum infection and their immunologic responses to alpha toxin.
    Johnson S; Driks MR; Tweten RK; Ballard J; Stevens DL; Anderson DJ; Janoff EN
    Clin Infect Dis; 1994 Oct; 19(4):761-4. PubMed ID: 7803645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.